A detailed history of Al Ti Global, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Al Ti Global, Inc. holds 20,565 shares of AMGN stock, worth $5.76 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
20,565
Previous 35,937 42.77%
Holding current value
$5.76 Million
Previous $11.2 Billion 40.99%
% of portfolio
0.16%
Previous 0.3%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $4.76 Million - $5.19 Million
-15,372 Reduced 42.77%
20,565 $6.63 Billion
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $2.38 Million - $2.89 Million
-9,061 Reduced 20.14%
35,937 $11.2 Billion
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $2.52 Million - $3.05 Million
9,387 Added 26.36%
44,998 $12.8 Billion
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $9.11 Million - $10.3 Million
35,611 New
35,611 $10.3 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Al Ti Global, Inc. Portfolio

Follow Al Ti Global, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Al Ti Global, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Al Ti Global, Inc. with notifications on news.